prednimustine has been researched along with Leukemia, Myeloid, Acute in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Diehl, V; Engert, A; Franklin, J; Hasenclever, D; Josting, A; Loeffler, M; Scholz, M | 1 |
Baum, ES; Gaynon, PS; Hammond, D; Krivit, W | 1 |
Brandt, L; Könyves, I | 1 |
Jensen, MK; Juul, K; Pedersen-Bjergaard, J; Sørensen, P | 1 |
Andersson, M; Pedersen-Bjergaard, J; Philip, P | 1 |
2 trial(s) available for prednimustine and Leukemia, Myeloid, Acute
Article | Year |
---|---|
Prednimustine in adult acute myeloid leukaemia.
Topics: Adult; Aged; Blood Cell Count; Chlorambucil; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Prednimustine; Time Factors; Vincristine | 1979 |
Phase II trial of Prednimustine. Leo-1031 (NSC-134087) in acute non-lymphocytic leukemia.
Topics: Adult; Aged; Chlorambucil; Clinical Trials as Topic; Female; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Male; Middle Aged; Prednimustine | 1979 |
3 other study(ies) available for prednimustine and Leukemia, Myeloid, Acute
Article | Year |
---|---|
Impact of first- and second-line treatment for Hodgkin's lymphoma on the incidence of AML/MDS and NHL--experience of the German Hodgkin's Lymphoma Study Group analyzed by a parametric model of carcinogenesis.
Topics: Algorithms; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Doxorubicin; Etoposide; Glyoxal; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prednimustine; Prednisone; Procarbazine; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome; Vinblastine; Vincristine | 2011 |
Phase II trial of prednimustine in children with recurrent cancer: a Children's Cancer Study Group report.
Topics: Adolescent; Adult; Carcinoma, Hepatocellular; Child; Child, Preschool; Chlorambucil; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infant; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Liver Neoplasms; Male; Neoplasms; Neuroblastoma; Prednimustine | 1982 |
High risk of therapy-related leukemia and preleukemia after therapy with prednimustine, methotrexate, 5-fluorouracil, mitoxantrone, and tamoxifen for advanced breast cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Female; Fluorouracil; Humans; Leukemia, Myeloid, Acute; Methotrexate; Middle Aged; Mitoxantrone; Prednimustine; Preleukemia; Risk Factors; Survival Rate; Tamoxifen | 1990 |